85.81
0.89 (1.05%)
0.89 (1.05%)
Actualizar a Tiempo Real
Mercado Regular
| Volume | 300,037 |
|
|||||
| Noticias | - |
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Novartis AG | NVS | NYSE | Certificado de Depósito |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 0.89 | 1.05% | 85.81 | 09:28:40 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 85.29 | 85.19 | 85.83 | 84.92 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio |
|---|---|---|---|---|
| 2,967 | 300,037 | 85.47 | 25,645,024 | - |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 09:28:39 | 24 | 85.81 | USD |
Período:
Tipo de Línea:
Información Financiera Novartis AG NVS
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 187.31B | 2.18B | 2.18B | 50.39B | 21.44B | 10.63 | 8.40 |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | 3.20 | 3.92% | 08/03/22 | - | - |
Noticias sobre Novartis AG NVS
| Fecha | Hora | Fuente | Noticia |
|---|---|---|---|
| 15/8/2022 | 01:05 | Dow Jones News | Novartis Phase 3 Canopy-A Trial Didn't Meet Primary Endpoint |
| 12/8/2022 | 04:35 | Dow Jones News | Novartis Says Two Children Treated With Gene-Therapy.. |
| 08/8/2022 | 07:45 | InvestorsHub NewsWire | The Power of Science to Stop a Killer |
| 19/7/2022 | 05:50 | Edgar (US Regulatory) | Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16.. |
| 19/7/2022 | 01:22 | Dow Jones News | Novartis 2Q Earnings, Sales Fell |
| 01/7/2022 | 02:34 | TipRanks | Everything You Need to Know If You’re Worried About.. |
| 29/6/2022 | 06:39 | TipRanks | Novartis Leans on Job Cuts to Boost Bottom line |
| 23/6/2022 | 01:31 | Dow Jones News | Novartis to Boost Development of Anti-Malaria,.. |
| 23/6/2022 | 00:46 | Dow Jones News | Novartis Tumor Treatment Gets US Nod |
| 22/6/2022 | 10:57 | Dow Jones News | Precision BioSciences in Collaboration With Novartis, Shares.. |
| 22/6/2022 | 06:00 | GlobeNewswire Inc. | Alladapt Announces Completion of Oversubscribed $119 Million.. |
| 22/6/2022 | 02:05 | Dow Jones News | Novartis Loses in Appeal Over Gilenya Patent |
Histórico NVS
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
